Don't want ads? Subscribe or login now.

Ex-Pfizer Worker Seeks No Time For Paxlovid Insider Trading

By Emilie Ruscoe · July 15, 2024, 10:51 PM EDT

A former Pfizer employee argued that he shouldn't go to prison after a Manhattan federal jury convicted him of insider trading over clinical trial results for the drug Paxlovid, pointing out...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

USA v. DAGAR

Case Number

1:23-cr-00319

Court

New York Southern

Nature of Suit

Date Filed

June 28, 2023

Recent Articles By Emilie

November 03, 2025
Biotech Co. Agrees To Reforms After Co-Founder's Conviction
October 28, 2025
Ex-Philips CEO Can't Undo Finding He Misled Shareholders
October 27, 2025
Moderna Says Vax Efficacy Math Doesn't Show Investor Fraud
October 17, 2025
Sana Biotech Fights Investor Fraud Claims Over Trial Data
October 09, 2025
Tivity Health Investors Seek Final OK Of $17M Settlement
October 06, 2025
2 Firms To Lead Humana Investor Suit Over Post-COVID Costs
September 16, 2025
BrainStorm Can't Shed Investors' ALS Treatment Trial Claims
September 11, 2025
Dental Supply Co.'s $84M Price-Fixing Deal Gets Final OK
August 28, 2025
Telehealth Co. Faces Investor Suit Over Revenue Reversal
August 22, 2025
Ex-Pharma Exec Leaked Bankruptcy Deliberations, Suit Says